Viewing Study NCT04268368


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2026-02-18 @ 9:44 AM
Study NCT ID: NCT04268368
Status: UNKNOWN
Last Update Posted: 2020-02-17
First Post: 2020-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immune Related-adverse Events in Patients Receiving Immune Checkpoint Inhibitors
Sponsor: Università Politecnica delle Marche
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Lung Cancer View
None Renal Cell Carcinoma View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer View
None immune checkpoint inhibitors View
None immune related adverse events View
None nivolumab View
None pembrolizumab View
None avelumab View
None durvalumab View
None atezolizumab View